Longer-lived imaging agents could hasten Alzheimer's research
Monday, February 22, 2016 - 07:30
in Health & Medicine
In the past few years, despite the best efforts of scientists and medical researchers, drug after drug designed to slow or stop the progression of Alzheimer's disease has failed in clinical trials. Some had no effect on the progression of the disease, others made patients' symptoms worse and yet others produced results so equivocal it was difficult to interpret them.